NextCure, Inc. logo

NextCure, Inc.

NextCure, is a biopharmaceutical company focused on discovering and developing first-in-class next generation immuno-oncology-based drugs.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.nextcure.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
9000 Virginia Manor Road Suite 200, MD, 20705
Beltsville
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

NextCure is leveraging and applying its current Functional, Integrated, NextCure Discovery in Immuno Oncology (FIND-IOTM) technology to functional screening approaches for the identification of novel targets to address limited treatment options for patients that do not respond to standard treatments or existing immune therapies.

In Jan 2016, NextCure raised a $67 Mn Series A financing led by Canaan Partners, Lilly Asia Ventures, OrbiMed Advisors, Pfizer Inc. and Sofinnova Ventures.